Cox, A. J., Gleeson, M, Pyne, D. B., Saunders, P. U., Clancy, R. L. & Fricker, P. A. (2004). Valtrex therapy for Epstein-Barr virus reactivation and upper respiratory symptoms in elite runners. Medicine & Science in Sports & Exercise, 36 (7), 1104-1110. doi: 10.1249/01.MSS.0000131957.40985.2B
APA (7th ed.) CitationCox, A. J., Gleeson, M., Pyne, D. B., Saunders, P. U., Clancy, R. L., & Fricker, P. A. (2004). Valtrex therapy for Epstein-Barr virus reactivation and upper respiratory symptoms in elite runners. Medicine & Science in Sports & Exercise, 36(7), 1104-1110.
Chicago Style (17th ed.) CitationCox, A. J., M. Gleeson, D. B. Pyne, P. U. Saunders, R. L. Clancy, and P. A. Fricker. "Valtrex Therapy for Epstein-Barr Virus Reactivation and Upper Respiratory Symptoms in Elite Runners." Medicine & Science in Sports & Exercise 36, no. 7 (2004): 1104-1110.
MLA (9th ed.) CitationCox, A. J., et al. "Valtrex Therapy for Epstein-Barr Virus Reactivation and Upper Respiratory Symptoms in Elite Runners." Medicine & Science in Sports & Exercise, vol. 36, no. 7, 2004, pp. 1104-1110.